Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kelfred HoldingsHKSE:01134 +2.98%45 FCF Margin % is 8.10% as of Dec. 2025, which is 175% above its 10-year median of 2.95. GuruFocus rates HKSE:01134 with a GF Score™ of 45/100 and a GF Value™ of HK$0.44 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Kelfred Holdings ranks better than 63.42% on this metric.
The historical rank and industry rank for Kelfred Holdings's FCF Margin % or its related term are showing as below:
HKSE:01134'
s FCF Margin % Range Over the Past 10 Years
Min: -6.21 Med: 2.95 Max: 6.61
Current: 5.19
During the past 10 years, the highest FCF Margin % of Kelfred Holdings was 6.61%. The lowest was -6.21%. And the median was 2.95%.
HKSE:01134's FCF Margin % is ranked better than 63.42% of 812
companies
in the Medical Devices & Instruments industry
Industry Median: -0.875
vs HKSE:01134: 5.19
The historical data trend for Kelfred Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01134 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Kelfred Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kelfred Holdings FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kelfred Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Kelfred Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kelfred Holdings (HKSE:01134) has a FCF Margin % of 8.10% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kelfred Holdings and its competitors. This is 175% above median its historical median of 2.95. According to the industry distribution chart, Kelfred Holdings ranks #297 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 36.6%.
Is Kelfred Holdings' FCF Margin % too high?
Kelfred Holdings' current FCF Margin % of 8.10% is 175% above median its 10-year median of 2.95. Based on the distribution chart, Kelfred Holdings ranks #297 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Kelfred Holdings has a GF Score™ of 45/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kelfred Holdings' FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kelfred Holdings ranks #297 out of 812 companies for FCF Margin %. This puts Kelfred Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kelfred Holdings and its competitors. Kelfred Holdings's current FCF Margin % is 8.10%, which is 175% above median its own 10-year median of 2.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelfred Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kelfred Holdings (HKSE:01134) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$0.44, compared to a current price of HK$0.24 — trading 45% below its estimated fair value. The current FCF Margin % is 8.10%, which is 175% above median its 10-year median of 2.95. Kelfred Holdings' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Kelfred Holdings (HKSE:01134), the current FCF Margin % is 8.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kelfred Holdings (HKSE:01134) Overvalued in 2026?
Based on GuruFocus' analysis, Kelfred Holdings stock appears to be undervalued.
The current stock price of HK$0.24 is trading 45% below its estimated GF Value™ of HK$0.44.
GuruFocus considers Kelfred Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:01134:
FCF Margin %: 8.10% (175% above median its 10-year median of 2.95)
GF Value™: HK$0.44 vs. price of HK$0.24 (45% below fair value)
No single metric tells the full story. See the HKSE:01134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kelfred Holdings Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in the manufacturing and sales of eyewear products. It produces and sells a wide range of spectacle frames and sunglasses mainly through original design manufacturing (ODM) and original equipment manufacturing (OEM) business models. The group offers integrated and customised services, including product design and development, raw materials procurement, production, quality control, packaging, and delivery. The Group also offers (OBM) products under the brand name Miga. It operates in Italy, the United Kingdom, Hong Kong, the U.S., PRC, India, Spain, the Philippines, Japan, Australia, France, and other countries. It generates a majority of its revenue from the United Kingdom.
45GF Score
Get the complete analysis for HKSE:01134
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01134 has been successfully added to your 
